CO logo

Global Cord Blood (CO) EBITDA

Annual EBITDA

$94.78 M
+$7.12 M+8.12%

March 31, 2022

Summary

Performance

1-Year Change

+8.12%

3-Year Change

+46.49%

5-Year Change

+90.14%

15-Year Change

+90.14%

CO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$94.78 M
CO annual EBITDA is currently at an all-time high

3-Year Low

$87.67 M
CO annual EBITDA is currently +8.12% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2022
CO previous annual earnings announcement was published on Mar 31, 2022

Next Annual Earnings Report Date

N/A
CO next annual earnings announcement has not yet been scheduled

OtherCOprofitabilitymetrics:

Annual Revenue

$193.54 M
CO annual revenue is $193.54 million

Annual Net Income

$78.00 M
CO annual net profit is $78.00 million

Annual EBIT

$94.78 M
CO annual earnings before interest & taxes is $94.78 million

Annual EPS

$0.64
CO annual earnings per share is $0.64

Quarterly EBITDA

$22.36 M
-$1.03 M-4.42%

March 31, 2022

Summary

Performance

3-Month Change

-4.42%

1-Year Change

-2.13%

3-Year Change

+69.9%

5-Year Change

+135.56%

CO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$24.78 M
CO quarterly EBITDA is currently -9.75% below its historical high of $24.78 million

3-Year Low

$22.36 M
CO quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
CO previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
CO next earnings announcement has not yet been scheduled

OtherCOprofitabilitymetrics:

Quarterly Revenue

$46.76 M
CO quarterly revenue is $46.76 million

Quarterly Net Income

$16.47 M
CO quarterly net profit is $16.47 million

Quarterly EBIT

$22.36 M
CO quarterly earnings before interest & taxes is $22.36 million

Quarterly EPS

$0.14
CO quarterly earnings per share is $0.14

TTM EBITDA

$94.76 M
-$486.70 K-0.51%

March 31, 2022

Summary

Performance

3-Month Change

-0.51%

1-Year Change

+17.76%

3-Year Change

+31.75%

5-Year Change

+31.75%

CO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$95.25 M
CO TTM EBITDA is currently -0.51% below its historical high of $95.25 million

3-Year Low

$94.76 M
CO TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
CO previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
CO next earnings announcement has not yet been scheduled

OtherCOprofitabilitymetrics:

TTM Revenue

$193.54 M
CO TTM revenue is $193.54 million

TTM Net Income

$77.97 M
CO TTM net profit is $77.97 million

TTM EBIT

$94.76 M
CO TTM earnings before interest & taxes is $94.76 million

TTM EPS

$0.64
CO TTM earnings per share is $0.64

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$94.78 M
CO annual EBITDA is $94.78 million

Annual Net Income

$78.00 M
CO annual net profit is $78.00 million

Annual Interest Expense

-
CO annual interest expense value is unknown

Annual Income Tax

$18.42 M
CO annual income tax is $18.42 million

Annual D&A

$7.46 M
CO annual depreciation & amortization is $7.46 million

CO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.1%-2.1%+17.8%
3 y3 years+46.5%+69.9%+31.8%
5 y5 years+90.1%+135.6%+31.8%

CO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-7.5%-4.4%at low-0.5%at low
5 y5-yearat high-31.7%-9.7%-16.4%-0.5%-24.1%
alltimeall timeat high-101.8%-9.7%-105.2%-0.5%-102.0%

Global Cord Blood EBITDA History

DateAnnualQuarterlyTTM
Mar 2022
$94.78 M(+8.1%)
$22.36 M(-4.4%)
$94.76 M(-0.5%)
Dec 2021
-
$23.40 M(-5.6%)
$95.25 M(+5.2%)
Sep 2021
-
$24.78 M(+2.3%)
$90.55 M(+5.4%)
Jun 2021
-
$24.23 M(+6.0%)
$85.87 M(+6.7%)
Mar 2021
$87.67 M(+0.4%)
$22.85 M(+22.2%)
$80.47 M(+1.8%)
Dec 2020
-
$18.70 M(-7.0%)
$79.01 M(-3.7%)
Sep 2020
-
$20.10 M(+6.7%)
$82.02 M(-0.6%)
Jun 2020
-
$18.83 M(-12.0%)
$82.51 M(+2.9%)
Mar 2020
$87.35 M(+35.0%)
$21.39 M(-1.4%)
$80.15 M(+11.4%)
Dec 2019
-
$21.70 M(+5.4%)
$71.92 M(+13.1%)
Sep 2019
-
$20.59 M(+25.0%)
$63.61 M(+8.9%)
Jun 2019
-
$16.47 M(+25.2%)
$58.42 M(+2.6%)
Mar 2019
$64.70 M(+19.5%)
$13.16 M(-1.7%)
$56.93 M(+10.7%)
Dec 2018
-
$13.39 M(-13.0%)
$51.44 M(+0.8%)
Sep 2018
-
$15.39 M(+2.7%)
$51.03 M(+6.1%)
Jun 2018
-
$14.98 M(+95.4%)
$48.11 M(+4.4%)
Mar 2018
$54.14 M(+8.6%)
$7.67 M(-40.9%)
$46.10 M(-3.8%)
Dec 2017
-
$12.98 M(+4.0%)
$47.92 M(-4.2%)
Sep 2017
-
$12.48 M(-3.7%)
$50.00 M(+7.6%)
Jun 2017
-
$12.97 M(+36.6%)
$46.48 M(+10.2%)
Mar 2017
$49.85 M(+5.9%)
$9.49 M(-37.0%)
$42.20 M(+6.8%)
Dec 2016
-
$15.06 M(+68.1%)
$39.52 M(+1.6%)
Sep 2016
-
$8.96 M(+3.3%)
$38.89 M(-0.6%)
Jun 2016
-
$8.68 M(+27.3%)
$39.14 M(-0.2%)
Mar 2016
$47.09 M(-4.9%)
$6.82 M(-52.8%)
$39.23 M(-4.6%)
Dec 2015
-
$14.44 M(+56.7%)
$41.10 M(+6.7%)
Sep 2015
-
$9.21 M(+5.1%)
$38.52 M(-2.4%)
Jun 2015
-
$8.76 M(+0.7%)
$39.47 M(-4.6%)
Mar 2015
$49.51 M
$8.70 M(-26.6%)
$41.36 M(-6.1%)
Dec 2014
-
$11.85 M(+16.6%)
$44.07 M(+0.4%)
Sep 2014
-
$10.16 M(-4.7%)
$43.89 M(+0.4%)
DateAnnualQuarterlyTTM
Jun 2014
-
$10.66 M(-6.5%)
$43.72 M(+2.4%)
Mar 2014
$48.72 M(+16.1%)
$11.40 M(-2.3%)
$42.68 M(+6.1%)
Dec 2013
-
$11.67 M(+16.9%)
$40.21 M(+0.3%)
Sep 2013
-
$9.99 M(+3.9%)
$40.10 M(+5.6%)
Jun 2013
-
$9.62 M(+7.6%)
$37.96 M(+4.6%)
Mar 2013
$41.95 M(+45.8%)
$8.93 M(-22.7%)
$36.29 M(+8.2%)
Dec 2012
-
$11.56 M(+47.3%)
$33.55 M(+19.9%)
Sep 2012
-
$7.85 M(-1.3%)
$27.98 M(+8.6%)
Jun 2012
-
$7.95 M(+28.4%)
$25.77 M(+6.5%)
Mar 2012
$28.78 M(+22.3%)
$6.19 M(+3.3%)
$24.19 M(+0.9%)
Dec 2011
-
$6.00 M(+6.4%)
$23.96 M(+1.7%)
Sep 2011
-
$5.63 M(-11.5%)
$23.57 M(+3.8%)
Jun 2011
-
$6.37 M(+6.7%)
$22.71 M(+13.0%)
Mar 2011
$23.53 M(+56.6%)
$5.97 M(+6.5%)
$20.10 M(+12.6%)
Dec 2010
-
$5.60 M(+17.3%)
$17.85 M(+9.8%)
Sep 2010
-
$4.78 M(+27.1%)
$16.26 M(+5.9%)
Jun 2010
-
$3.76 M(+1.2%)
$15.36 M(+27.7%)
Mar 2010
$15.02 M(-983.4%)
$3.71 M(-7.5%)
$12.03 M(+50.1%)
Dec 2009
-
$4.01 M(+3.7%)
$8.01 M(+182.6%)
Sep 2009
-
$3.87 M(+802.2%)
$2.84 M(-311.6%)
Jun 2009
-
$429.00 K(-242.6%)
-$1.34 M(-28.5%)
Mar 2009
-
-$300.80 K(-74.1%)
-$1.88 M(+8.9%)
Dec 2008
-$1.70 M(+205.6%)
-$1.16 M(+281.3%)
-$1.72 M(+148.5%)
Sep 2008
-
-$305.10 K(+187.3%)
-$693.40 K(+31.3%)
Jun 2008
-
-$106.20 K(-28.4%)
-$528.10 K(-10.7%)
Mar 2008
-
-$148.30 K(+10.8%)
-$591.10 K(+5.1%)
Dec 2007
-$556.50 K(+1805.8%)
-$133.80 K(-4.3%)
-$562.40 K(+31.2%)
Sep 2007
-
-$139.80 K(-17.4%)
-$428.60 K(+48.4%)
Jun 2007
-
-$169.20 K(+41.5%)
-$288.80 K(+141.5%)
Mar 2007
-
-$119.60 K
-$119.60 K
Dec 2006
-$29.20 K
-
-

FAQ

  • What is Global Cord Blood annual EBITDA?
  • What is the all time high annual EBITDA for Global Cord Blood?
  • What is Global Cord Blood annual EBITDA year-on-year change?
  • What is Global Cord Blood quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Global Cord Blood?
  • What is Global Cord Blood quarterly EBITDA year-on-year change?
  • What is Global Cord Blood TTM EBITDA?
  • What is the all time high TTM EBITDA for Global Cord Blood?
  • What is Global Cord Blood TTM EBITDA year-on-year change?

What is Global Cord Blood annual EBITDA?

The current annual EBITDA of CO is $94.78 M

What is the all time high annual EBITDA for Global Cord Blood?

Global Cord Blood all-time high annual EBITDA is $94.78 M

What is Global Cord Blood annual EBITDA year-on-year change?

Over the past year, CO annual EBITDA has changed by +$7.12 M (+8.12%)

What is Global Cord Blood quarterly EBITDA?

The current quarterly EBITDA of CO is $22.36 M

What is the all time high quarterly EBITDA for Global Cord Blood?

Global Cord Blood all-time high quarterly EBITDA is $24.78 M

What is Global Cord Blood quarterly EBITDA year-on-year change?

Over the past year, CO quarterly EBITDA has changed by -$486.70 K (-2.13%)

What is Global Cord Blood TTM EBITDA?

The current TTM EBITDA of CO is $94.76 M

What is the all time high TTM EBITDA for Global Cord Blood?

Global Cord Blood all-time high TTM EBITDA is $95.25 M

What is Global Cord Blood TTM EBITDA year-on-year change?

Over the past year, CO TTM EBITDA has changed by +$14.29 M (+17.76%)